TScan Therapeutics' SWOT analysis: innovative t-cell therapy stock faces pivotal year
TScan Therapeutics Inc. (NASDAQ:TCRX), a clinical-stage biopharmaceutical company with a market capitalization of $139.57 million, is poised at a critical juncture in its development of innovative ...
Enphase Energy's SWOT analysis: solar stock faces headwinds amid growth potential
Enphase Energy Inc . (NASDAQ:ENPH), a leading provider of solar energy solutions, finds itself at a crossroads as it navigates a complex landscape of market challenges and growth opportunities. The ...
CSLM Acquisition Corp to be delisted from Nasdaq
CSLM Acquisition Corp, a special purpose acquisition company currently trading at $12.77 with a market cap of $74.01 million, ...
Jefferies lifts Infosys stock price target to INR2,250
The revised price target of INR2,250 is based on a price-to-earnings (PE) multiple of 29 times, as mentioned by the Jefferies ...